U.S. Physical Therapy Stock (NYSE:USPH)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$66.39

52W Range

$58.19 - $93.50

50D Avg

$67.75

200D Avg

$77.99

Market Cap

$956.35M

Avg Vol (3M)

$199.64K

Beta

1.16

Div Yield

$1.82 (2.90%)

USPH Company Profile


U.S. Physical Therapy, Inc., through its various subsidiaries, manages a network of outpatient physical therapy facilities. These clinics deliver a range of services, including rehabilitation before and after surgery, treatment for musculoskeletal conditions, recovery from sports-related trauma, proactive health measures, assistance for workers recovering from injuries, and care for neurological conditions. The company's business is divided into two primary divisions: Physical Therapy Operations and Industrial Injury Prevention Services. Within its industrial segment, it provides specialized services like on-site injury avoidance and recovery programs, strategies for enhancing physical performance, pre-employment screening tests, assessments of an individual's work capacity, and workplace ergonomic reviews. These offerings are delivered by licensed physical therapists and expert certified athletic trainers to a diverse clientele, including Fortune 500 corporations, insurance providers, and their associated contractors. By the end of 2021, specifically December 31st, the company had established 591 operational clinics across 39 states, in addition to overseeing 35 other physical therapy sites. Established in 1990, the company maintains its headquarters in Houston, Texas.

Show More

Industry

Medical - Care Facilities

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

4,034

IPO Date

May 29, 1992

Website

USPH Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 24Dec 23
Other Revenues Including Management Contract Revenues and Industrial Injury Prevention Services Revenues$130.56M$110.79M$90.25M
Net Patient Revenues$650.43M$560.55M$514.56M

Fiscal year ends in Dec 25 | Currency in USD

USPH Financial Summary


Dec 25Dec 24Dec 23
Revenue$780.99M$671.35M$604.80M
Operating Income$80.43M$63.21M$52.06M
Net Income$15.06M$26.46M$14.67M
EBITDA$109.66M$86.91M$74.37M
Basic EPS$1.42$1.84$1.28
Diluted EPS$1.42$1.84$1.28

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q1 26May 07, 26 | 10:30 AM
Q4 25Feb 26, 26 | 10:30 AM
Q3 25Nov 06, 25 | 10:30 AM

Peer Comparison


TickerCompany
KMTSKestra Medical Technologies, Ltd.
SEMSelect Medical Holdings Corporation
CNMDCONMED Corporation
AHCOAdaptHealth Corp.
NEOGNeogen Corporation
HCSGHealthcare Services Group, Inc.
GDRXGoodRx Holdings, Inc.
ASTHAstrana Health, Inc.
PNTGThe Pennant Group, Inc.
ZBIOZenas BioPharma, Inc.